R. Andrew Eckert serves as a director of BD (Becton, Dickinson and Company), a global medical technology company headquartered in Franklin Lakes, New Jersey. Eckert has been a member of the board since 2016.
Mr. Eckert serves as a senior advisor to Permira, a global private equity firm, since December 2022. From August 2020 to August 2021, Mr. Eckert served as chief executive officer (CEO) of Zelis Inc., a provider of healthcare cost management and payments solutions. From 2017 until the sale of the company in October 2019, he served as president and CEO of Acelity L.P. Inc., a global wound care company. From 2015 until the sale of the company in 2016, Eckert served as CEO of Valence Health, Inc., a healthcare information technology and services company. Prior thereto, he served as CEO of TriZetto Corporation, a payer technology solutions firm, and CEO of CRC Health Group, a provider of specialized behavioral healthcare services. Eckert also serves as lead director of Fortrea Holdings Inc. and served as chairman of Varian Medical Systems Inc.
Eckert is a leader in the growing field of healthcare information technology, with extensive experience as an executive officer of several healthcare companies. He also brings to the Board a deep knowledge of operations, strategic planning, product development and marketing and has valuable corporate governance insight gained from having served as chief executive officer of publicly-held companies and as a director of other public companies.